Indian Drugmaker Warned After Refusing FDA Inspection

Drug Industry Daily
A A
Indian drug manufacturer SkyLark CMC drew a warning letter from the FDA by denying the agency investigator access to its manufacturing facility in Ahmedabad, Gujarat.

To View This Article:

Login

Subscribe To Drug Industry Daily